Clinical Trial: Global Atrophie Biomarker Evaluation Study (GABiE)

U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT03935126) titled 'Global Atrophie Biomarker Evaluation Study (GABiE)' on April 30, 2019.

Brief Summary: To investigate the use of microperimetry and SS-OCT in assessing the natural changes of retinal sensitivity and anatomy in the perilesional zone of geographic atrophy areas in patients with dry age-related macular degeneration.

Study Type: Interventional

Condition: Age-related Macular Degeneration

Intervention: Diagnostic Test: Diagnostics

Diagnostics

Recruitment Status: Recruiting

Sponsor: Boehringer Ingelheim

Information provided by (Responsible Party): Boehringer Ingelheim

Published by HT Digital Content Services with permission from Hea...